Subcutaneously administered Menopur(R), a new highly purified human menopausal gonadotropin, causes significantly fewer injection site reactions than Repronex(R) in subjects undergoing in vitro fertilization

BACKGROUND: The safety and tolerability of a new highly purified, urine-derived human menopausal gonadotropin (hMG) preparation [Menopur(R)] was compared with a currently available hMG [Repronex (R)] in women undergoing in vitro fertilization (IVF). METHODS: This was a randomized, open-label, parall...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Keye, William R, Webster, Bobby, Dickey, Richard, Somkuti, Stephen, Crain, Jack, Scobey, M Joseph
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2005
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1309620/
https://ncbi.nlm.nih.gov/pubmed/16280073
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7827-3-62
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky